Use of prior information to stabilize a population data analysis.
about
An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathwayPharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in TanzaniaCombining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical dataAnalysis of population pharmacokinetic data using NONMEM and WinBUGS.The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical dataIntegration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation.A Bayesian approach for population pharmacokinetic modelling of sirolimus.Pharmacokinetic/pharmacodynamic modelling in oncological drug development.Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake.The utility of modeling and simulation approaches to evaluate immunogenicity effect on the therapeutic protein pharmacokinetics.Optimal design in pediatric pharmacokinetic and pharmacodynamic clinical studies.A Bayesian Approach for Population Pharmacokinetic Modeling of Alcohol in Japanese IndividualsPharmacology-based toxicity assessment: towards quantitative risk prediction in humans.Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants.Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia.dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap.Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma.Population pharmacokinetic analysis of voriconazole from a pharmacokinetic study with immunocompromised Japanese pediatric subjects.Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach.Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transportersConsiderations in analyzing single-trough concentrations using mixed-effects modeling.A model-based approach to dose selection in early pediatric development.A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects.Mechanism-based PK-PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans.Population pharmacokinetics of atorvastatin and its active metabolites in children and adolescents with heterozygous familial hypercholesterolemia: selective use of informative prior distributions from adults.Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia.Evaluation of uncertainty parameters estimated by different population PK software and methods.The application of a Bayesian approach to the analysis of a complex, mechanistically based model.Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.Intranasal sufentanil/ketamine analgesia in children.Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated malariaPopulation Pharmacokinetics of the Antimalarial Amodiaquine: A Pooled Analysis to Optimize Dosing
P2860
Q28540807-D53B7A96-0363-41EC-9D10-93EA3D7247A6Q28550488-1E6BD689-9EF6-4D41-A6F4-A1267C7E28C5Q30666721-8C719D72-72C8-4F40-9D01-5E65BAA446B9Q30982415-322BEAB6-22CD-4616-875D-014AB2B1B5DFQ33212737-F85AAB5E-EFAE-4204-90C6-67488B101372Q34149022-19BBDA41-25E2-40B1-8C65-91CC3237D3EFQ35827649-AD7C4F04-8D0F-4582-A51E-643F0660A6A8Q35827802-3EBB099F-3517-437A-962B-DA522BB50C14Q36055576-E6776AD7-AA3D-4F2C-AC4E-50B83AF1A134Q36336064-02B7BEBA-1FC0-4849-8653-354A20F2D804Q36341664-36D7D485-5E2A-4AB3-B939-9298DD526E53Q37540015-1D372CD6-F511-454B-AB0E-8A4B3B7CD82BQ38058750-B08B49F0-5769-46DA-BD41-03C68B7A7AAFQ38315070-41344F47-906A-45F2-A9B0-F40CA1AFA1CBQ38650468-E01135A6-676C-40BF-A06B-DB448B0CD4E5Q38771635-2E261BF0-5329-441C-A10C-66EF3FE9F366Q38782947-A0678A84-C984-4801-8778-5BE9695BE31DQ38905356-8D925B3B-E9BD-4A99-B8A2-2B7A5B825F3BQ39289346-78C7189B-DC0B-43F2-8DA6-F4E342958D49Q39300563-2BC2B438-0084-476B-933E-CC7F97D8A40CQ39570922-2E0D1CB7-225D-412A-9B4D-D212394756CBQ40675074-ADCF7A74-03F3-4289-A01D-AB1E1912B8CFQ41759104-11E54EB0-5E9B-415D-9ED5-A80F8C6376E5Q42282801-ED093D72-4B1E-40CC-92C8-A51D88964104Q42613107-919268E2-B40D-42A7-992B-7CB7BFCA27E4Q43182469-69A5DDDE-616F-478B-B223-DA2286A3C127Q43740705-956EAB0A-E121-4471-BEFC-14F5B54E95F4Q48442724-0B0F7FE6-69B6-4D05-B2A7-85C99BF2A637Q51265123-0071C13F-E026-4842-BC02-4B086A683C8EQ51458897-D9F80E92-5240-4A01-97F8-7866C587614EQ51628085-1711B720-C9E5-423A-BBC8-35AA0D4AFABFQ51925341-76AF6E9C-94CC-44E0-A24C-43EEF0D12A86Q51931195-135D8161-D09B-4814-A597-09B86B18AE99Q53687968-6D8D91E5-8E64-4595-BD59-0D80D140E27BQ54250760-EDF0A5BF-C6DA-4526-924A-C0DD6B040BBCQ56354961-4C0FD5E4-6513-4547-9EDA-8B7A1C7DE4DBQ56358106-94CDA67C-3831-4C12-8B11-922884D0F7BE
P2860
Use of prior information to stabilize a population data analysis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Use of prior information to stabilize a population data analysis.
@ast
Use of prior information to stabilize a population data analysis.
@en
type
label
Use of prior information to stabilize a population data analysis.
@ast
Use of prior information to stabilize a population data analysis.
@en
prefLabel
Use of prior information to stabilize a population data analysis.
@ast
Use of prior information to stabilize a population data analysis.
@en
P2093
P356
P1476
Use of prior information to stabilize a population data analysis.
@en
P2093
Mats O Karlsson
Per O Gisleskog
Stuart L Beal
P2888
P304
P356
10.1023/A:1022972420004
P577
2002-12-01T00:00:00Z
P6179
1030293579